This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
National Industrial Hemp Council Offers CBD Policy Recommendations to FDA
Group participated in FDA’s CBD working group in July.
The National Industrial Hemp Council (NIHC) has filed comments with the U.S. Food And Drug Administration (FDA) to help direct its work on establishing a policy of enforcement discretion on CBD products.
The comments were filed after the NIHC participated in a listening session with the FDA’s CBD Working Group on July 27. Members of NIHC’s Consumer Protection Task Force emphasized the importance of establishing basic safety standards and committed to follow up in writing with detailed policy recommendations. Later that week, the NIHC met with the White House Office of Management and Budget (OMB) as part of what is expected to be the forthcoming regulatory process.